Società Dr. Reddy's Laboratories Limited NSE India S.E.
Azioni
DRREDDY
INE089A01023
Prodotti farmaceutici
Tempo differito
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
6.204 INR | -1,47% | +4,24% | +7,01% |
Attività
- vendite di farmaci generici (79,9%): farmaci da prescrizione di marca o generici e farmaci OTC;
- vendite di principi attivi (15,7%). Il gruppo fornisce anche servizi farmaceutici personalizzati;
- altro (4,4%): vendite di prodotti biofarmaceutici generici, sviluppo di agenti molecolari, ecc.
Le vendite nette sono distribuite geograficamente come segue: India (18,8%), Stati Uniti (45%), Russia (9,9%) e altro (26,3%).
Numero di dipendenti: 25 863
Vendite per attività
INR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Global Generics
86,9
%
| 179 170 | 83,6 % | 213 768 | 86,9 % | +19,31% |
Pharmaceutical Services and Active Ingredients
11,8
%
| 30 740 | 14,3 % | 29 069 | 11,8 % | -5,44% |
Others
1,2
%
| 2 870 | 1,3 % | 3 042 | 1,2 % | +5,99% |
Vendite per regione
INR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
43,4
%
| 80 564 | 37,6 % | 106 683 | 43,4 % | +32,42% |
Others
27,4
%
| 68 962 | 32,2 % | 67 469 | 27,4 % | -2,16% |
India
20,5
%
| 43 986 | 20,5 % | 50 499 | 20,5 % | +14,81% |
Russia
8,6
%
| 20 879 | 9,7 % | 21 228 | 8,6 % | +1,67% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 57 | 02/04/18 |
Parag Agarwal
DFI | Director of Finance/CFO | - | 02/11/20 |
Chairman | 56 | 18/01/93 | |
Gunupati Prasad
CHM | Chairman | 63 | 08/04/86 |
B. Phanimitra
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/23 |
K. Randhir Singh
CMP | Compliance Officer | - | 17/03/22 |
Archana Bhaskar
IRO | Public Communications Contact | 57 | 01/06/17 |
Amith Agarwal
IRC | Investor Relations Contact | - | - |
Jayanth Sridhar
PRN | Corporate Officer/Principal | - | - |
Vivek Mittal
LAW | General Counsel | - | 01/05/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Gunupati Prasad
CHM | Chairman | 63 | 08/04/86 |
Chairman | 56 | 18/01/93 | |
Kalpana Morparia
BRD | Director/Board Member | 73 | 05/06/07 |
Shikha Sharma
BRD | Director/Board Member | 64 | 31/01/19 |
Leo Puri
BRD | Director/Board Member | 63 | 25/10/18 |
Claudio Albrecht
BRD | Director/Board Member | - | 10/05/23 |
Sanjiv Mehta
BRD | Director/Board Member | 63 | 29/12 |
Director/Board Member | 64 | 07/01/22 | |
Alpna Seth
BRD | Director/Board Member | 60 | 19/09/23 |
Penny Wan
BRD | Director/Board Member | - | 28/01/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 166 874 039 | 152 715 641 ( 91,52 %) | 345 564 ( 0,2071 %) | 91,52 % |
Coordinate società
Dr. Reddy's Laboratories Ltd.
Door No. 8-2-337 Road No. 3
500034, Hyderabad
+91 40 4900 2900
http://www.drreddys.comSocietà del gruppo
Nome | Categoria e settore |
---|---|
Aurigene Discovery Technologies Ltd.
Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. |
Biotechnology
|
Dr. Reddy's Laboratories SA
Dr. Reddy's Laboratories SA Pharmaceuticals: MajorHealth Technology Part of Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories SA is a Swiss company that develops, manufactures and sells pharmaceutical products. The private company is based in Basel, Switzerland. |
Pharmaceuticals: Major
|
Aurigene Pharmaceutical Services Ltd.
Aurigene Pharmaceutical Services Ltd. BiotechnologyHealth Technology Aurigene Pharmaceutical Services Ltd. is a contract research, development, and manufacturing organization. It offer integrated and standalone services for medicinal chemistry, biology, preclinical services, DMPK studies, development, and manufacturing for clinical phase I-III programs. The company is headquartered in Bangalore, India. |
Biotechnology
|
Settore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+26,47% | 664 Mrd | |
+30,25% | 567 Mrd | |
-6,33% | 354 Mrd | |
+19,35% | 330 Mrd | |
+4,23% | 286 Mrd | |
+14,32% | 234 Mrd | |
+4,95% | 199 Mrd | |
-10,02% | 196 Mrd | |
-4,04% | 148 Mrd |
- Borsa valori
- Azioni
- Azione DRREDDY
- Azione DRREDDY
- Società Dr. Reddy's Laboratories Limited